Aims: Although adequate clinical management of patients with hypercholesterolemia without a history of known cardiovascular disease is essential for prevention, these subjects are often disregarded. Furthermore, the scientific literature on primary cardiovascular prevention is not as rich as that on secondary prevention; finally, physicians often lack adequate tools for the effective management of subjects in primary prevention and have to face some unsolved relevant issues. This document aims to discuss and review the evidence available on this topic and provide practical guidance. Data synthesis: Available algorithms and risk charts represent the main tool for the assessment of cardiovascular risk in patients in primary prevention. The accuracy of such an estimate can be substantially improved considering the potential contribution of some additional risk factors (C-reactive protein, lipoprotein(a), family history of cardiovascular disease) and conditions (environmental pollution, sleep quality, socioeconomic status, educational level) whose impact on the cardiovascular risk has been better understood in recent years. The availability of non-invasive procedures to evaluate subclinical atherosclerosis may help to identify subjects needing an earlier intervention. Unveiling the presence of these conditions will improve cardiovascular risk estimation, granting a more appropriate intervention. Conclusions: The accurate assessment of cardiovascular risk in subjects in primary prevention with the use of algorithms and risk charts together with the evaluation of additional factors will allow physicians to approach each patient with personalized strategies, which should translate into an increased adherence to therapy and, as a consequence, a reduced cardiovascular risk.

LDL-cholesterol control in the primary prevention of cardiovascular diseases. An expert opinion for clinicians and health professionals / Poli, Andrea; Catapano, Alberico L; Corsini, Alberto; Manzato, Enzo; Werba, José Pablo; Catena, Gabriele; Cetin, Irene; Cicero, Arrigo F G; Cignarella, Andrea; Colivicchi, Furio; Consoli, Agostino; Landi, Francesco; Lucarelli, Maurizio; Manfellotto, Dario; Marrocco, Walter; Parretti, Damiano; Perrone Filardi, Pasquale; Pirillo, Angela; Sesti, Giorgio; Volpe, Massimo; Marangoni, Franca. - In: NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. - ISSN 1590-3729. - 33:2(2023), pp. 245-257. [10.1016/j.numecd.2022.10.001]

LDL-cholesterol control in the primary prevention of cardiovascular diseases. An expert opinion for clinicians and health professionals

Corsini, Alberto;Landi, Francesco;Sesti, Giorgio
Writing – Original Draft Preparation
;
Volpe, Massimo;
2023

Abstract

Aims: Although adequate clinical management of patients with hypercholesterolemia without a history of known cardiovascular disease is essential for prevention, these subjects are often disregarded. Furthermore, the scientific literature on primary cardiovascular prevention is not as rich as that on secondary prevention; finally, physicians often lack adequate tools for the effective management of subjects in primary prevention and have to face some unsolved relevant issues. This document aims to discuss and review the evidence available on this topic and provide practical guidance. Data synthesis: Available algorithms and risk charts represent the main tool for the assessment of cardiovascular risk in patients in primary prevention. The accuracy of such an estimate can be substantially improved considering the potential contribution of some additional risk factors (C-reactive protein, lipoprotein(a), family history of cardiovascular disease) and conditions (environmental pollution, sleep quality, socioeconomic status, educational level) whose impact on the cardiovascular risk has been better understood in recent years. The availability of non-invasive procedures to evaluate subclinical atherosclerosis may help to identify subjects needing an earlier intervention. Unveiling the presence of these conditions will improve cardiovascular risk estimation, granting a more appropriate intervention. Conclusions: The accurate assessment of cardiovascular risk in subjects in primary prevention with the use of algorithms and risk charts together with the evaluation of additional factors will allow physicians to approach each patient with personalized strategies, which should translate into an increased adherence to therapy and, as a consequence, a reduced cardiovascular risk.
2023
cardiovascular disease; cardiovascular risk; ldl-cholesterol; primary prevention; risk factors
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
LDL-cholesterol control in the primary prevention of cardiovascular diseases. An expert opinion for clinicians and health professionals / Poli, Andrea; Catapano, Alberico L; Corsini, Alberto; Manzato, Enzo; Werba, José Pablo; Catena, Gabriele; Cetin, Irene; Cicero, Arrigo F G; Cignarella, Andrea; Colivicchi, Furio; Consoli, Agostino; Landi, Francesco; Lucarelli, Maurizio; Manfellotto, Dario; Marrocco, Walter; Parretti, Damiano; Perrone Filardi, Pasquale; Pirillo, Angela; Sesti, Giorgio; Volpe, Massimo; Marangoni, Franca. - In: NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. - ISSN 1590-3729. - 33:2(2023), pp. 245-257. [10.1016/j.numecd.2022.10.001]
File allegati a questo prodotto
File Dimensione Formato  
Poli_LDL-cholesterol-control-in-primary-prevention_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 736.43 kB
Formato Adobe PDF
736.43 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1669250
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact